Evidence map›Paper›PMID 34696310›Full record

ArticleVaccines2021

School-Level Variation in Coverage of Co-Administered dTpa and HPV Dose 1 in Three Australian States.

Cassandra Vujovich-Dunn, Susan Rachel Skinner, Julia Brotherton, Handan Wand, Jana Sisnowski, Rebecca Lorch, Mark Veitch, Vicky Sheppeard, Paul Effler, Heather Gidding and 19 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. COVID Vaccines in Adolescents and Young Adults.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2022
    Guideline
  2. Article
  3. Review
  4. Article
  5. Vaccines · 2024
    Article
  6. Article
  7. Using World Cafés to engage an Australian culturally and linguistically diverse community around human papillomavirus vaccination.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 1 country.

Cassandra Vujovich-DunnThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.ORCID 0000-0002-7938-8030
Susan Rachel SkinnerChildren's Hospital Westmead, Sydney Children's Hospitals Network, Sydney 2145, Australia.
Julia BrothertonPopulation Health, VCS Foundation Ltd., East Melbourne, Melbourne 3053, Australia.
Handan WandThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.ORCID 0000-0002-8279-7652
Jana SisnowskiThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.
Rebecca LorchThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.
Mark VeitchDepartment of Health and Human Services, Tasmanian Government, Hobart 7001, Australia.
Vicky SheppeardCommunicable Diseases Branch, Health Protection NSW, St Leonards, Sydney 2065, Australia.
Paul EfflerDepartment of Health, Communicable Disease Control Directorate, East Perth 6000, Australia.
Heather GiddingSchool of Population Health, University of New Souh Wales, Sydney 2052, Australia.
Alison VennMenzies Institute for Medical Research, University of Tasmania, Tasmanian 7000, Australia.ORCID 0000-0001-7090-1398
Cristyn DaviesChildren's Hospital Westmead, Sydney Children's Hospitals Network, Sydney 2145, Australia.ORCID 0000-0003-1506-3285
Jane HockingMelbourne School of Population and Global Health, University of Melbourne, Carlton, Melbourne 3010, Australia.
Lisa J WhopNational Centre for Epidemiology & Population Health, Australian National University, Canberra 0200, Australia.ORCID 0000-0003-4816-2933
Julie LeaskFaculty of Medicine and Health, Sydney Nursing School, University of Sydney, Camperdown, Sydney 2006, Australia.
Karen CanfellCancer Research Division, Cancer Council, Brisbane 2011, Australia.
Lena SanciMedicine, Dentistry and Health Sciences, University of Melbourne, Carlton, Melbourne 3010, Australia.
Megan SmithSchool of Public Health, University of Sydney, Camperdown, Sydney 2006, Australia.ORCID 0000-0002-0401-2653
Melissa KangWestmead Clinical School, University of Sydney, Sydney 2006, Australia.
Meredith Temple-SmithMedicine, Dentistry and Health Sciences, University of Melbourne, Carlton, Melbourne 3010, Australia.ORCID 0000-0003-1296-9591
Michael KiddSouthgate Institute for Health, Flinders University, Adelaide 5042, Australia.
Sharyn BurnsSchool of Population Health, Curtin University, Perth 6102, Australia.
Linda SelveySchool of Public Health, University of Queensland, Brisbane 4072, Australia.ORCID 0000-0001-8493-0974
Dennis MeijerImmunisation Unit, Health Protection NSW, St Leonards, Sydney 2065, Australia.
Sonya EnnisImmunisation Unit, Health Protection NSW, St Leonards, Sydney 2065, Australia.
Chloe A ThomsonDepartment of Health, Communicable Disease Control Directorate, East Perth 6000, Australia.
Nikole LaneDepartment of Health and Human Services, Tasmanian Government, Hobart 7001, Australia.
John KaldorThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.
Rebecca GuyThe Kirby Institute, University of New South Wales, Kensington, Sydney 2052, Australia.
The University of Sydney · AUUNSW Sydney · AUThe University of Melbourne · AUAustralian National University · AUGovernment of Western Australia Department of Health · AUNew South Wales Department of Health · AUTasmanian GovernmentCancer Council Queensland · AUCurtin University · AUFlinders University · AUThe University of Queensland · AUUniversity of Tasmania · AU

Funding

National Health and Medical Research Council APP1132344
6 · The paper itself

Abstract

backgroundAustralian adolescents are routinely offered HPV and dTpa (diphtheria, tetanus, pertussis) vaccines simultaneously in the secondary school vaccination program. We identified schools where HPV initiation was lower than dTpa coverage and associated school-level factors across three states.

methodsHPV vaccination initiation rates and dTpa vaccination coverage in 2016 were calculated using vaccine databases and school enrolment data. A multivariate analysis assessed sociodemographic and school-level factors associated with HPV initiation being >5% absolute lower than dTpa coverage.

resultsOf 1280 schools included, the median school-level HPV initiation rate was 85% (interquartile range (IQR):75-90%) and the median dTpa coverage was 86% (IQR:75-92%). Nearly a quarter (24%) of all schools had HPV vaccination initiation >5% lower than dTpa coverage and 11 % had >10% difference. School-level factors independently associated with >5% difference were remote schools (aOR:3.5, 95% CI = 1.7-7.2) and schools in major cities (aOR:1.8, 95% CI = 1.0-3.0), small schools (aOR:3.3, 95% CI = 2.3-5.7), higher socioeconomic advantage (aOR:1.7, 95% CI = 1.1-2.6), and lower proportions of Language-background-other-than-English (aOR:1.9, 95% CI = 1.2-3.0).

conclusionThe results identified a quarter of schools had lower HPV than dTpa initiation coverage, which may indicate HPV vaccine hesitancy, and the difference was more likely in socioeconomically advantaged schools. As hesitancy is context specific, it is important to understand the potential drivers of hesitancy and future research needs to understand the reasons driving differential uptake.

Indexed as

adolescent vaccinationcancer preventiondifferential uptakeevaluation and impactimplementationschool-based immunisationvaccinationvaccine specific hesitancy

Identifiers

PMID34696310
PMCPMC8537995
OpenAlexW3205974776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.